Authors
Loading...
Randomized trial identifies PRELP and TAGLN as biomarkers in colorectal cancer, suggesting implications for prognosis.
Judaki et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: